Effect of tirofiban on C-reactive protein in non-ST–elevation myocardial infarction
- 31 January 2004
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 147 (1), 54-57
- https://doi.org/10.1016/s0002-8703(03)00447-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Platelet-erythrocyte interactions enhance αIIbβ3 integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivoBlood, 2002
- Inflammatory role of platelets in acute coronary syndromesHeart, 2001
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanNew England Journal of Medicine, 2001
- Novel Inflammatory Markers of Coronary RiskCirculation, 1999
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Activated platelets signal chemokine synthesis by human monocytes.JCI Insight, 1996
- Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic StrategyCirculation, 1995
- ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES IN HUMAN DISEASEAnnual Review of Medicine, 1994
- Role of granulocytes in endothelial injury in coronary heart disease in humansAtherosclerosis, 1991